For more than 40 years, ICU Medical has supported healthcare providers around the world with technologies designed to enhance patient safety, streamline workflows, and improve the delivery of care. In Canada, ICU Medical plays a vital role in supporting hospitals and healthcare organizations through a wide range of IV therapy, oncology, and critical-care solutions available to HealthPRO Canada members.

Behind their global reach lies a focus on reliability and partnership. With operations and support teams across Canada, ICU Medical combines product innovation with localized service to help ensure continuity and performance in clinical settings. Their solutions include IV administration systems, needle-free connectors (NFC), closed-system drug transfer devices, and infusion pumps, all designed to support safe and efficient patient care.

DID YOU KNOW?
ICU Medical’s portfolio traces its roots to a single innovation, the needle-free connector, introduced more than three decades ago to help reduce the risk of needlestick injuries and bloodstream infections.

Building on that foundation, the company refined its signature Clave™ technology, which has been cited in numerous studies showing significant reductions in central line–associated bloodstream infections (CLABSI) when standardized across hospitals.

Since then, ICU Medical has expanded its innovation footprint, holding hundreds of patents worldwide and continuing to invest in research, design and manufacturing focused on safety, efficiency and sustainability.

One recent peer-reviewed study published in SAGE Journals provides further support for ICU Medical’s approach in infusion and device safety. You can access the full study here and review how evidence aligns with these technologies highlighting the importance of device design.

“While there are multiple factors contributing to thrombotic catheter occlusion, one of the most significant is the displacement potential of the NFC design. The displacement feature influences the likelihood of blood reflux into the catheter lumen on connection or disconnection of the flush syringe. The current trend in the literature in both in vitro and clinical studies indicates that neutral and anti-reflux NFCs are associated with minimal reflux volume and a lower incidence of catheter occlusion. Utilization of a NFC with lower occlusion risk can minimize therapy delays, catheter replacement, costly thrombolytic treatments, and increased infection potential.”

– Dr. Marcia Ryder, Q&A Session October 15, 2025.

Across Canada, ICU Medical’s team provides hospitals with technical support, training and product expertise to maintain reliable and effective infusion and drug delivery systems. Their commitment to operational excellence and customer collaboration supports HealthPRO Canada members in delivering consistent, high-quality care.

Looking ahead, ICU Medical continues to align its innovation and service strategies with evolving healthcare needs, helping hospitals strengthen patient safety, operational resilience and clinical outcomes across the continuum of care.